Back to PE Pentwater Capital Management LP

BCYC

13 quarters

Position history for PEPentwater Capital Management LP's holdings in Bicycle Therapeutics plc

No. Pentwater Capital Management exited its BCYC (Bicycle Therapeutics) position in Q2 2022. Its Q1 2022 13F listed 14,000 shares worth $614,000. Pentwater Capital Management first reported BCYC in Q2 2019 and held it in 12 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$642,000

Total Shares Change

-63,822

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q2
Latest
Exited
0
-100.0%
$00.0%$17.16
0
2022-Q1
Decreased
14,000
-64.6%
$614,0000.0%$42.54
0
2021-Q4
Increased
39,500
+229.2%
$2.4M0.0%$58.50
42
2021-Q3
Unchanged
12,000
0.0%
$499,0000.0%$39.07
0
2021-Q2
Unchanged
12,000
0.0%
$364,0000.0%$30.08
0
2021-Q1
Unchanged
12,000
0.0%
$358,0000.0%$26.87
0
2020-Q4
Unchanged
12,000
0.0%
$215,0000.0%$18.57
0
2020-Q3
Decreased
12,000
-4.0%
$229,0000.0%$19.44
0
2020-Q2
Unchanged
12,500
0.0%
$197,0000.0%$16.13
0
2020-Q1
Decreased
12,500
-76.2%
$171,0000.0%$13.81
0
2019-Q4
Decreased
52,587
-8.8%
$496,0000.0%$9.75
0
2019-Q3
Decreased
57,687
-9.6%
$657,0000.0%$11.51
0
2019-Q2
New
63,822
-
$642,0000.0%$10.06
34

Other major holders of BCYC: Baker Bros. Advisors LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used